Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NUVL compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name
NUVL
Nuvalent, Inc.
Change
Mkt cap
Revenue
Revenue
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
NUVL
Nuvalent, Inc.
vs
GMAB
Genmab A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NUVL: latest quarter not drawable. GMAB: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NUVL, solid
GMAB, dashed
NUVL
Nuvalent, Inc.
Change
123.96
▲
+0.02%
· post 123.96
Mkt cap
$9.8B
GMAB
Genmab A/S
Change
54.93
▼
−3.74%
· post 54.99
Closed
Nov 2 '26
Mkt cap
$36.7B
vs
Compare
Closed
Nov 2 '26
NUVL
Nuvalent, Inc.
vs
GMAB
Genmab A/S
123.96
▲
+0.02%
post 123.96
Price
54.93
▼
−3.74%
post 54.99
$9.8B
Mkt cap
$36.7B
Change
Change
NUVL
123.96
▲
+0.02%
vs
GMAB
54.93
▼
−3.74%
Closed
Nov 2 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NUVL
0
None
Shared
0
No disclosed counterparties: NUVL.
Only GMAB
1
COAG
Hemab Therapeutics
customer
Role chip = supplier or customer
Source: SEC EDGAR